相似文献
1
Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine.
Can J Cardiol. 2007 Aug;23 Suppl A(Suppl A):28A-33A. doi: 10.1016/s0828-282x(07)71003-6.
2
Prospects for personalized cardiovascular medicine: the impact of genomics.
J Am Coll Cardiol. 2005 Nov 1;46(9):1615-27. doi: 10.1016/j.jacc.2005.06.075. Epub 2005 Oct 10.
3
Precision Medicine and Personalized Medicine in Cardiovascular Disease.
Adv Exp Med Biol. 2018;1065:589-605. doi: 10.1007/978-3-319-77932-4_36.
4
The Future of Genetics and Genomics: Closing the Phenotype Gap in Precision Medicine.
Circulation. 2016 Jun 21;133(25):2634-9. doi: 10.1161/CIRCULATIONAHA.116.022547.
5
Precision Medicine, Cardiovascular Disease and Hunting Elephants.
Prog Cardiovasc Dis. 2016 May-Jun;58(6):651-60. doi: 10.1016/j.pcad.2016.02.004. Epub 2016 Feb 21.
6
Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Clin Genet. 2017 Mar;91(3):355-370. doi: 10.1111/cge.12881. Epub 2016 Nov 30.
7
Predicting disease using genomics.
Nature. 2004 May 27;429(6990):453-6. doi: 10.1038/nature02624.
8
Genomics, genetic epidemiology, and genomic medicine.
Clin Gastroenterol Hepatol. 2005 Apr;3(4):320-8. doi: 10.1016/s1542-3565(05)00085-6.
9
Exploring predisposition and treatment response--the promise of genomics.
Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):56-63. doi: 10.1016/j.pcad.2012.04.006.
10
Impact and influence of "omics" technology on hyper tension studies.
Int J Cardiol. 2017 Feb 1;228:1022-1034. doi: 10.1016/j.ijcard.2016.11.179. Epub 2016 Nov 23.
引用本文的文献
1
Decoding the Nexus: Cellular and Molecular Mechanisms Linking Stroke and Neurotoxic Microenvironments in Brain Cancer Patients.
Biomolecules. 2024 Nov 26;14(12):1507. doi: 10.3390/biom14121507.
2
Knee Arthroscopy in the Era of Precision Medicine: A Comprehensive Review of Tailored Approaches and Emerging Technologies.
Cureus. 2024 Oct 6;16(10):e70932. doi: 10.7759/cureus.70932. eCollection 2024 Oct.
3
Navigating the Frontier: Emerging Techniques for Detecting Microvascular Complications in Type 2 Diabetes Mellitus: A Comprehensive Review.
Cureus. 2024 Jan 31;16(1):e53279. doi: 10.7759/cureus.53279. eCollection 2024 Jan.
4
A predictive multiscale model of in-stent restenosis in femoral arteries: linking haemodynamics and gene expression with an agent-based model of cellular dynamics.
J R Soc Interface. 2022 Mar;19(188):20210871. doi: 10.1098/rsif.2021.0871. Epub 2022 Mar 30.
5
Multiscale Computational Modeling of Vascular Adaptation: A Systems Biology Approach Using Agent-Based Models.
Front Bioeng Biotechnol. 2021 Nov 2;9:744560. doi: 10.3389/fbioe.2021.744560. eCollection 2021.
6
Cardiovascular precision medicine: Bad news from the front?
Porto Biomed J. 2017 Jul-Aug;2(4):99-101. doi: 10.1016/j.pbj.2017.03.006. Epub 2017 Jul 1.
7
A novel system-level approach using RNA-sequencing data identifies miR-30-5p and miR-142a-5p as key regulators of apoptosis in myocardial infarction.
Sci Rep. 2018 Oct 2;8(1):14638. doi: 10.1038/s41598-018-33020-x.
8
Low T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Evidence from a Proteomic Approach.
Int J Mol Sci. 2015 Nov 6;16(11):26687-705. doi: 10.3390/ijms161125973.
9
Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
Am J Psychiatry. 2015 Feb 1;172(2):124-38. doi: 10.1176/appi.ajp.2014.14010076.
10
Big heart data: advancing health informatics through data sharing in cardiovascular imaging.
IEEE J Biomed Health Inform. 2015 Jul;19(4):1283-90. doi: 10.1109/JBHI.2014.2370952. Epub 2014 Nov 14.
本文引用的文献
1
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
J Am Coll Cardiol. 2006 Nov 7;48(9):1733-41. doi: 10.1016/j.jacc.2006.06.063. Epub 2006 Oct 17.
2
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways.
Circ Res. 2006 Sep 29;99(7):706-14. doi: 10.1161/01.RES.0000243995.74395.f8. Epub 2006 Aug 31.
3
Mapping the murine cardiac 26S proteasome complexes.
Circ Res. 2006 Aug 18;99(4):362-71. doi: 10.1161/01.RES.0000237386.98506.f7. Epub 2006 Jul 20.
4
A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11288-93. doi: 10.1073/pnas.0509937103. Epub 2006 Jul 14.
5
Association of parental heart failure with risk of heart failure in offspring.
N Engl J Med. 2006 Jul 13;355(2):138-47. doi: 10.1056/NEJMoa052948.
6
The future prospects of pharmacogenetics in oral anticoagulation therapy.
Br J Clin Pharmacol. 2006 Jun;61(6):746-51. doi: 10.1111/j.1365-2125.2006.02679.x.
7
Genetics of familial combined hyperlipidemia.
Curr Opin Lipidol. 2006 Jun;17(3):285-90. doi: 10.1097/01.mol.0000226121.27931.3f.
8
Mechanisms of disease: Genetic mechanisms of atrial fibrillation.
Nat Clin Pract Cardiovasc Med. 2006 May;3(5):276-82. doi: 10.1038/ncpcardio0509.
9
The long QT syndrome family of cardiac ion channelopathies: a HuGE review.
Genet Med. 2006 Mar;8(3):143-55. doi: 10.1097/01.gim.0000204468.85308.86.
10
Genetic susceptibility to coronary artery disease: from promise to progress.
Nat Rev Genet. 2006 Mar;7(3):163-73. doi: 10.1038/nrg1805.
Zotero 插件